Cell Collection to Study Eye Diseases

Abroad (travel likely)Recruiting

Conditions

Retinal Disease · AMD · Retinal Degeneration · Retinitis Pigmentosa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (Nancy Chen, B.S.) · nancy.chen@nih.gov · 240-551-7020

Study leads

Fnu Ruchi, Ph.D.
Principal Investigator
National Eye Institute (NEI)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Age-related Macular Degeneration (AMD) · Geographic Atrophy (GA)

Abroad (travel likely)RecruitingPHASE3

Chandler, United States · Phoenix, United States

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD

Abroad (travel likely)RecruitingPHASE2

Deerfield Beach, United States · Fort Lauderdale, United States

High Resolution Retinal Imaging

Stargardts · Retinitis Pigmentosa · Age-related Macular Degeneration

Abroad (travel likely)Recruiting

Philadelphia, United States

Natural History Study of Patients With EYS-Associated RP

Retinitis Pigmentosa · Eye Diseases

Abroad (travel likely)Recruiting

Moscow, Russia